|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation, depletion, accretion, and amortization | |||||
| Impairment of oil and natural gas properties | |||||
| Deferred income taxes | |||||
| Total commodity derivatives gains, net | |||||
| Commodity derivative settlements received | |||||
| (Gains) losses on marketable equity securities | |||||
| Impairment and loss on real estate held for sale | |||||
| Loss on sale of assets | |||||
| Amortization of debt issuance costs | |||||
| Stock-based compensation | |||||
| Right of use asset amortization | |||||
| Changes in operating assets and liabilities: | |||||
| Oil and natural gas sales receivable | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Accrued compensation and benefits | |||||
| Revenue and royalties payable | |||||
| Payments on operating lease liability | |||||
| Settlements of asset retirement obligations | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of proved properties | |||||
| Acquisition of industrial gas properties | |||||
| Capital expenditures | |||||
| Industrial Gas Properties | |||||
| Oil and Natural Gas Properties | |||||
| Total capital expenditures | |||||
| Property and equipment expenditures | |||||
| Proceeds from sale of oil and natural gas properties, net | |||||
| Sale of real estate and other, net | |||||
| Net cash (used in) provided by investing activities: | |||||
| Cash flows from financing activities: | |||||
| Borrowings on credit facility | |||||
| Payments on credit facility | |||||
| Payment of fees for credit facility | |||||
| Payments on insurance premium finance note | |||||
| Exercise of warrant | |||||
| Debt and equity financing costs | |||||
| Shares withheld to settle tax withholding obligations for restricted stock awards | |||||
| Dividends paid | |||||
| Related party share repurchase | |||||
| Proceeds from underwritten offering | |||||
| Repurchases of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash and equivalents | |||||
| Cash and equivalents, beginning of year | |||||
| Cash and equivalents, end of year | |||||
| Cash payments for interest | |||||
| Operating lease liability and right of use asset | |||||
| Issuance of stock for conversion of related party secured note payable | |||||
Loading...